Meeting program
Saturday, November 4
*All times are in EET.
13:15 - 13:30 EET Opening remarks
13:30 - 14:30 EET Session 1: Immunotherapy in indolent lymphomas
Hall A
- How to approach relapsed follicular lymphoma
M Ladetto (Italy) - Overview of mantle cell lymphoma
M Dreyling (Germany) - Panel discussion
All speakers
13:30 - 14:30 EET Session 2: Inherited red blood cell disorders
Hall B
- Iron overload in inherited red blood cell disorders (pathopysiological and clinical aspects)
D Girelli (Italy) - Hereditary hemolytic anemias: How to diagnose
N Roy (United Kingdom) - Panel discussion
All speakers
14:30 - 14:45 EET Coffee break
14:45 - 15:30 EET Satellite Symposium
Hall A
15:30 - 15:45 EET Coffee break
15:45 - 16:45 EET Session 3: Novel therapeutic approaches in acute myeloid leukemia (AML)
Hall A
- Targeted therapies in AML
Speaker to be announced - Title to be announced
Speaker to be announced - Panel discussion
All speakers
15:45 - 16:45 EET Session 4: Pediatric acute myeloid leukemia (AML)
Hall B
- Modeling pediatric leukemia
Speaker to be announced - Therapeutically actionable mechanisms in MLL rearranged pediatric leukemia
Speaker to be announced - Panel discussion
All speaker
16:45 - 17:00 EET Coffee break
17:00 - 18:00 EET Session 5: Novel agents in multiple myeloma
Hall A
- From trials to clinical practice: Novel immunotherapies in MM, focus on BCMA-directed drugs
S Manier (France) - Novel targets and drugs in multiple myeloma
D Coriu (Romania) - Panel discussion
All speakers
17:00 - 18:00 EET Session 6: Acute acquired thrombosis and hemostasis challenges
Hall B
- Novel issues in hematological cancer patients (Thrombosis in unusual sites)
A Falanga (Italy) - Implications of liver disease to coagulation disorders
T Lisman (The Netherlands) - Panel discussion
All speaker
18:00 - 18:15 EET Coffee break
18:15 - 19:15 EET Regional Joint Symposium: Access to medicine / diagnostics
Hall A
19:15 - 19:30 EET Closing remarks
Hall A
Back